The Europe Vein illuminator Market would witness market growth of 30.7% CAGR during the forecast period (2020-2026). With Covid-19 infections rising globally, there is also widening apprehension about a shortage of essential life-saving devices and other essential medical supplies to stop the spread of this pandemic and provide optimum care to those infected. Additionally, for COVID-19 patients, who may need critical care, ventilators serve as a crucial treatment preference before pharmacological treatment is developed. In addition, a wide range of test-kits (antibody tests, self-administered, and others) require a rapid acceleration in the manufacturing process.
The devices are extremely compact, helping to reduce the time and discomfort during the puncture. Additionally, it is difficult to find the veins in juvenile, geriatric, and elderly patients, which may then lead to unsafe intravenous drug usage. It is expected that the adoption of vein illuminator would see rapid growth in small-scale hospitals, emergency departments, and outpatient treatment centers, thereby increasing demand growth.
These illuminator devices are widely adopted by end-use segments such as hospitals to improve patient convenience. In June 2016, the Ridgewood Valley Hospital invested in vein illuminators to simplify the procedure of IV insertion and blood drawing and also improve the administration of IV medications.
Vein illuminator is mainly used for the geriatric population and also for infants, as their veins cannot be easily located. The use of a vein illuminator decreases the chances of undesired damage or injuries that may occur when the veins are located. A vein illuminator utilizes hemoglobin's infrared absorption along with an arrangement of scanned lasers in order to detect a vein map directly on a patient's skin.
Increasing demand for painless injection in blood or intravenous access is also expected to drive market development. These devices are particularly beneficial for use in children and adults, as they reduce the risk of multiple needle pinching in infants and elderly patients. Illumination technology eases the work of clinicians by developing a main vein road map.
Based on Technology, the market is segmented into Infrared, Transillumination and Ultrasound. Based on End Use, the market is segmented into Hospitals, Blood Donation Camps, Academic Institutions and Other End-uses. Based on Application, the market is segmented into Blood Draw, Intravenous Access and Other Application. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: Vein Illuminator Market in Europe is expected to register a CAGR of 30.7% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AccuVein, Inc., Christie Medical Holdings, Inc. (Canadian Hospital Specialties Ltd.), TransLite, LLC, VueTek Scientific, LLC, ZD Medical, Inc., BK Medical Holding Company, Inc., Near Infrared Imaging, Inc., Sharn Anesthesia, Inc., Venoscope, LLC, and Cambridge Medical Group.
Market Segmentation:
By Technology
By End-Use
By Application
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 